Attending AUA 2024? Visit us at Booth #623
Profound Medical will be at AUA 2024! We are looking forward to collaborating, educating, and sharing how TULSA-PRO is a game-changing technology for prostate disease.
What is TULSA-PRO
TULSA-PRO is a game-changing technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The system is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum aiming to preserve the patient’s natural functional abilities 1. TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (“FDA”).
AUA TULSA-PRO Speakers
TULSA-PRO REIMBURSEMENT
Physician Testimonials
Patient Testimonials
1. Klotz, et al. “MP46-03-Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Three-year follow-up”. The Journal of Urology Suppl (2021)
106732B
CAUTION: TULSA-PRO® is approved for commercial sale in the USA (K191200) & EU (CE 2797[HR1] ) & Canada (103887). Rx only device.
For all other Regulatory jurisdictions, please contact us at info@profoundmedical.com for more information regarding the regulatory status of the device.